女性血清HER2表达:它与代谢综合征及其治疗药物反应的关联
Ruiwen Hu1, Xiaodie He2,3, Nan Gao1
1Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China, cpu.edu.cn.
International journal of endocrinology
|February 2, 2026
概括
人类表皮生长因子受体2 (HER2) 血清水平升高与女性代谢综合征 (MS) 的更高患病率有关. 较高的HER2可能是MS的独立风险因素和潜在生物标志物.
科学领域:
- 内分泌学 在内分泌学.
- 心血管疾病 心血管疾病
- 在瘤学瘤学.
背景情况:
- 代谢综合征 (MS) 是一组疾病,增加患心脏病,中风和2型糖尿病的风险.
- 人体表皮生长因子受体2 (HER2) 是一种参与细胞生长的蛋白质,经常在癌症中被研究,但它在代谢性疾病中的作用正在出现.
- 了解HER2和MS之间的关系可能会揭示新的诊断标志物和治疗点.
研究的目的:
- 调查血清人类表皮生长因子受体2 (HER2) 水平与女性代谢综合征 (MS) 之间的关联.
- 探索HER2水平与常见代谢药物的使用之间的关系.
主要方法:
- 根据诊断标准,一个由532名女性组成的队列被分为非MS和MS组.
- 测量了血清HER2水平,并将其分为四分位数.
- 使用斯皮尔曼相关性和逻辑回归分析来评估HER2,MS指标和药物使用之间的关联.
主要成果:
- 与没有MS的女性相比,MS患者的血清HER2水平显著更高 (p < 0.001).
- 多发性硬化症的患病率随着HER2四分位数的升高 (p < 0.001) 逐渐增加.
- 较高的HER2水平与MS风险因素 (如BMI,血压,葡萄糖,脂质) 有正相关,与年龄和某些药物的使用有负相关.
结论:
- 血清HER2水平升高与女性多发性硬化明显相关.
- 较高的HER2水平是MS的独立风险因素.
- 在女性中,HER2可能作为代谢综合征的潜在生物标志物.
相关概念视频
01:17Drug Metabolism: Phase I Reactions
4.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.9K
01:14Drug Metabolism: Phase II Reactions
5.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.1K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
226
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
00:52What is Metabolism?
131.8K
Overview
131.8K
01:21Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
01:21Drugs for Treatment of Constipation-Predominant IBS
833
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
833